This article discusses Issues concerning levothyroxine bloequlvalence and Interchangeability and provides pharmacists and other health care professionals with some practical advice on the substitution of levothyroxine and other drug products.
Get full access to this article
View all access options for this article.
References
1.
1.62 Fed. Reg. 43535, 1997
2.
Dong BJ,Hauck WW,Gambertoglio JG,Gee L.Bioequivalence of Generic and Brand-name Levothyroxine Products in the Treatment of Hypothyroidism.JAMA. 1997;277:1205-1213
3.
Escalante DA,Arem N,Arem R.Assessment of Enterchangeability of Two Brands of Levothyroxine Preparations with a Third-Generation.TSH Assay, Am J Med.. 1995;98:374-378
4.
AACE Clinical Practice Guidelines for the Evaluation and Treatment of Hyperthyroidism and Hypothyroidism.Endocrine Practice. 1995;1 (1): 56-62
5.
Singer PA,Cooper DS,Levy EG.Treatment Guidelines for Patients with Hyperthyroidism and Hypothyroidism.JAMA. 1995;273 (10): 808-812
6.
6.Omnibus Budget Reconciliation Act of 1990, Pub. L. 101-508, § 4401, 104 Stat. 1388, 151-52, 1990.
7.
Rosen DL.A Practical Guide to Drug Product Selection: Getting to Know the Food and Drug Administration's (FDA's) Approved Drug Products List (Orange Book) with Therapeutic Equivalence Evaluations.Journal of Pharmacy Practice. 1995;Vol. VII (June): 115-120
